Call Options

20 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.14 - $19.14 $237,698 - $300,498
15,700 New
15,700 $241,000
Q1 2024

May 15, 2024

BUY
$17.79 - $30.86 $346,905 - $601,770
19,500 New
19,500 $360,000
Q3 2023

Nov 15, 2023

BUY
$20.84 - $33.47 $389,708 - $625,889
18,700 New
18,700 $389,000
Q4 2022

Feb 14, 2023

BUY
$14.2 - $18.63 $49,700 - $65,205
3,500 Added 16.36%
24,900 $396,000
Q3 2022

Nov 14, 2022

BUY
$14.11 - $18.27 $301,954 - $390,978
21,400 New
21,400 $345,000
Q4 2021

Feb 14, 2022

SELL
$16.79 - $27.09 $206,517 - $333,207
-12,300 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$15.78 - $24.77 $194,094 - $304,671
12,300 New
12,300 $209,000
Q2 2021

Aug 06, 2021

SELL
$19.4 - $27.42 $966,119 - $1.37 Million
-49,800 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$25.02 - $54.99 $1.25 Million - $2.74 Million
49,800 New
49,800 $1.28 Million
Q4 2020

Feb 12, 2021

SELL
$41.04 - $56.79 $1.24 Million - $1.72 Million
-30,300 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$36.42 - $57.0 $302,286 - $473,100
8,300 Added 37.73%
30,300 $1.22 Million
Q2 2020

Aug 13, 2020

BUY
$39.26 - $52.73 $863,720 - $1.16 Million
22,000 New
22,000 $1.06 Million
Q1 2020

May 11, 2020

SELL
$31.65 - $46.87 $1.61 Million - $2.38 Million
-50,800 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$36.21 - $51.4 $1.84 Million - $2.61 Million
50,800 New
50,800 $2.19 Million
Q2 2019

Aug 20, 2019

SELL
$23.32 - $28.12 $874,500 - $1.05 Million
-37,500 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$16.17 - $27.38 $371,910 - $629,740
-23,000 Reduced 38.02%
37,500 $1.01 Million
Q4 2018

Feb 14, 2019

SELL
$14.32 - $22.92 $220,528 - $352,968
-15,400 Reduced 20.29%
60,500 $947,000
Q3 2018

Nov 14, 2018

BUY
$13.03 - $21.81 $988,977 - $1.66 Million
75,900 New
75,900 $1.58 Million
Q4 2017

Feb 14, 2018

SELL
$26.84 - $39.14 $791,780 - $1.15 Million
-29,500 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$29.49 - $38.37 $869,955 - $1.13 Million
29,500
29,500 $1.11 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.63B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.